+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Neonatal Fc receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Neonatal Fc receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Complement C1s inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement C1s inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-12 expression stimulants - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-12 expression stimulants - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Complement C3 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement C3 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
PD-1 and PD-L1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

PD-1 and PD-L1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 200 Pages
  • Global
From
Interleukin 6 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin 6 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Immunoglobulin inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Immunoglobulin inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
HIV integrase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

HIV integrase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
E-Selectin inhibitor- Pipeline Insight, 2024 - Product Thumbnail Image

E-Selectin inhibitor- Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
NF-kappa B Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

NF-kappa B Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Chemokine Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Chemokine Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-1 (IL-1) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
interleukin Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

interleukin Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
H Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

H Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Toll-Like Receptor Modulators - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-Like Receptor Modulators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
IL-6 Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

IL-6 Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Toll-like receptor 9 (TLR-9) Modulator - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-like receptor 9 (TLR-9) Modulator - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
P2X7 Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

P2X7 Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Prostaglandin Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Prostaglandin Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more